業績｜論文・出版物｜目次｜
 

Oncolytic reovirus-induced prostaglandin E2 production in human tumor cells.

Cryopreservation of hepatocyte organoid-derived cells generated from human iPS cells.

Oncolytic adenovirus serotype 35 mediated tumor growth suppression via efficient activation of antitumor immunity.

Considerations for developing CYP induction assays in hepatocytes: Insights from a multilaboratory study.

An in vitro safety evaluation model for assessing the effects of a chemical drug on the human intestinal barrier integrity using genetically modified Caco-2 cells expressing drug-metabolizing enzymes.

Two-dimensionally cultured functional hepatocytes generated from human induced pluripotent stem cell-derived hepatic organoids for pharmaceutical research.

Air-liquid interface culture alters the characteristics and functions of monolayers generated from human iPS cell‑derived enterocyte‑like cell organoids

Evaluation of the correlation between nuclear localization levels and genome editing efficiencies of Cas12a fused with nuclear localization signals.

Adenoviral Vector Construction II: Bacterial Systems

Approaches to the Treatment of Lifestyle-related Diseases Through the Regulation of Phospholipid Biosynthesis in the Liver

ヒト肝臓オルガノイドの創薬研究への応用

ヒトiPS細胞を利用した生体模倣システムの構築と医薬品評価への応用

実験におけるクリーンベンチ・安全キャビネットの使い方

改良型アデノウイルスベクターを用いた肝臓内の脂質の量と種類の制御による糖尿病の遺伝子治療法の開発

ヒト腸管オルガノイドを用いた医薬品開発プラットフォーム

肝臓内のリン脂質プロファイルに着目した、糖尿病に対する遺伝子治療法の開発

ヒトiPS細胞由来肝オルガノイドの樹立とその二次元培養による肝細胞の成熟化